EUVIMEDEUVIMED entdecken
Kommentar

Combined transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma

Myron Schwartz, Joshua Weintraub

Nature Clinical Practice Oncology · 2008-11 · 5 (11) · 630-631

DOI: 10.1038/ncponc1216 ↗

Kurz gefasst

Kommentar in der Zeitschrift Nature Clinical Practice Oncology, online erschienen am 19.08.2008. Verfasst von Myron Schwartz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Radiology, The Mount Sinai Liver Cancer Program, Mount Sinai School of Medicine, New York, NY 10029, USA. myron.schwartz@mo…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Surgery and Radiology, The Mount Sinai Liver Cancer Program, Mount Sinai School of Medicine, New York, NY 10029, USA. myron.schwartz@mountsinai.org

Zitieren

APA

Schwartz, M., & Weintraub, J. (2008). Combined transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma. Nature Clinical Practice Oncology, 5(11), 630-631. https://doi.org/10.1038/ncponc1216

Vancouver

Schwartz M, Weintraub J. Combined transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma. Nature Clinical Practice Oncology. 2008;5(11):630-631. doi:10.1038/ncponc1216

BibTeX
@article{Schwartz2008,
  author = {Schwartz, Myron and Weintraub, Joshua},
  title = {Combined transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma},
  journal = {Nature Clinical Practice Oncology},
  year = {2008},
  volume = {5},
  number = {11},
  pages = {630--631},
  doi = {10.1038/ncponc1216}
}
Kostenlos starten →